I thought it was an excellent result and presentation, being a LTH.
Not sure where there are more promising investment opportunities right now at this SP. Some companies with this MC or higher have no revenue.
The new products sound promising, some have relevance to telehealth which, of course, has accelerated with the pandemic. And the Ventitest reducing risk of crossinfection in ventilators is a major plus. Furthemore, the value of Uscom 1a being included in clinical guidelines cannot be underestimated, and really adds value to the co.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable